English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Objective:  The purpose of this study was to investigate the anticancer activity and the potential imaging use of the innovative combination of magnetic nanoparticles (MNPs)-Fe 3 O 4 , paclitaxel (PTX), and trastuzumab (Herceptin) in HER2-positive breast cancer.   Methods:  MNPs-Fe 3 O 4  was synthesized and underwent water phase transfer and hydrophobic molecular loading, and its surface was then coupled with Herceptin mono-antibody. The morphological characteristics of MNPs-Fe 3 O 4  were observed under transmission electron microscopy (TEM). Effects of PTX-Herceptin-MNPs-Fe 3 O 4  on breast cancer cells were evaluated using the 3-(4,5-dimethylthiazol-2-yl)-2,4-diphenyltetrazolium bromide assay and the flow cytometric apoptosis assay. To establish a xenograft model, we injected breast cancer SK-BR-3 cells into the left thighs of nude mice. We measured the effect of PTX-Herceptin-MNPs-Fe 3 O 4  on tumor growth by measuring tumor size and calculating inhibition rate with immunohistochemistry analysis further performed, and analyzed MNPs-Fe 3 O 4  accumulation in tumor lesions using  in vivo  magnetic resonance imaging and  in vivo  fluorescence imaging.   Results:  Most MNPs were in spherical shape of about 10 nm in diameter observed under TEM. PTX-Herceptin-MNPs-Fe 3 O 4  showed greater cytotoxic effects, and induced a higher apoptosis rate of SK-BR-3 cells than all the other groups, with corresponding changes of apoptosis-related proteins. Meanwhile, the  in vivo  tumor xenograft model showed that tumor inhibition rate in the PTX-Herceptin-MNPs-Fe 3 O 4  group was higher than in the PTX-Herceptin group. Furthermore, PTX-Herceptin-MNPs-Fe 3 O 4  enhanced the T2 imaging contrast enhancement effect on tumors in tumor-bearing mice.   Conclusion:  The novel PTX-Herceptin-MNPs-Fe 3 O 4  combination may represent a promising alternative breast cancer treatment strategy and may facilitate tumor imaging.

Preclinical Assessment of Paclitaxel- and Trastuzumab-Delivering Magnetic Nanoparticles Fe3O4 for Treatment and Imaging of HER2-Positive Breast Cancer